… Methods: We genotyped 25 prostate cancer susceptibility loci in 40,414 individuals and
derived a … 25 prostate cancer susceptibility SNPs in studies from the PRACTICAL consortium. …

… Following four systematic reviews, a multinational interview study, and expert group consensus
meetings, we defined the most clinically suitable definitions for (1) COS for localised and …

… Our international consortium used a large and diverse cohort of men treated with standard
curative therapies with long-term follow-up to develop and validate a well-performing, AJCC-…

… the Prostate Cancer Prevention Trial, which AUC was 0.66 for any prostate cancer and 0.71
for clinical significant prostate … of prostate cancer in PRACTICAL, a multinational consortium, …

… The Radiogenomics Consortium was established to facilitate … ) performed in prostate cancer
survivors demonstrated that it … on six cohorts comprising 3871 prostate cancer survivors. …

… Kaplan-Meier and Cox estimates of prostate cancer-free survival for patients in development
… Time of “failure” is age at any diagnosis of prostate cancer. Controls were censored at age …

… wellbeing) and 12 prostate cancer-specific items in the prostate cancer subscale to assess
function during the previous 7 days. A summary prostate cancer pain subscale and FACT-P …

… The ACTANE (Anglo, Canada, Texas, Australia, Norway, EU Biomed) Group, which is a
multinational consortium of research groups, has members from the United Kingdom, the state of …

… We developed a genetic risk model using data from 16,633 prostate cancer families. The …
cancer FH to predict the future risks. The risk model predicted incident prostate cancers in an …

Background Studies of active surveillance (AS) for prostate cancer (PCa) have focussed
predominantly on Caucasian populations. Little is known about the experience of Asian men, …